EMFO LLC’s Encompass Health EHC Stock Holding History

EMFO LLC’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-251	Closed	-$11K	–	321
2022 Q2	$11K	Hold	251	–	–	0.01%	265
2022 Q1	$14K	Hold	251	–	–	0.01%	267
2021 Q4	$13K	Hold	251	–	–	0.01%	276
2021 Q3	$15K	Hold	251	–	–	0.01%	284
2021 Q2	$16K	Buy	+251	New	+$16.7K	0.01%	264

Other funds holding EHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

EMFO LLC's EHC Position: Q3 2022 in Review

EMFO LLC sold out of Encompass Health (EHC) in Q3 2022, closing a stake of 251 shares — an estimated $11K sold.

EMFO LLC first reported a position in EHC in Q2 2021 and held it in 5 quarters. The position peaked at $16K in Q2 2021. 346 funds tracked by Wall St. Rank hold EHC as of Q3 2022.

EMFO LLC reported no remaining Encompass Health position as of Q3 2022 after selling out during the quarter.
EMFO LLC sold 251 Encompass Health shares in Q3 2022, an estimated $11K.
EMFO LLC first reported a position in Encompass Health in Q2 2021 and held it in 5 quarters.
EMFO LLC's Encompass Health position peaked at $16K in Q2 2021.
346 funds tracked by Wall St. Rank held Encompass Health as of Q3 2022.

Based on EMFO LLC's 13F filing for Q3 2022, filed 31 Oct 2022.